New York State Common Retirement Fund Dia Medica Therapeutics Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,800 shares of DMAC stock, worth $70,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800
Previous 26,300
55.13%
Holding current value
$70,328
Previous $102,000
20.59%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DMAC
# of Institutions
81Shares Held
8.02MCall Options Held
19.6KPut Options Held
16.5K-
Israel Englander Millennium Management LLC | New York, Ny1.19MShares$7.08 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX875KShares$5.22 Million11.8% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA665KShares$3.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY580KShares$3.45 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $158M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...